Christian Brieghel
0000-0002-1816-8106
Rigshospitalet
29 papers found
Refreshing results…
Improved Innate Immune Function in Patients with Chronic Lymphocytic Leukemia Treated with Targeted Therapy in Clinical Trials
Data from Clinical Outcomes in Patients with Multi-Hit TP53 Chronic Lymphocytic Leukemia Treated with Ibrutinib
Supplementary Data from Clinical Outcomes in Patients with Multi-Hit TP53 Chronic Lymphocytic Leukemia Treated with Ibrutinib
Author Correction: Early stimulated immune responses predict clinical disease severity in hospitalized COVID-19 patients
Correction: Different prognostic impact of recurrent gene mutations in chronic lymphocytic leukemia depending on IGHV gene somatic hypermutation status: a study by ERIC in HARMONY
Different prognostic impact of recurrent gene mutations in chronic lymphocytic leukemia depending on IGHV gene somatic hypermutation status: a study by ERIC in HARMONY
CLL-IPI applied in Binet A CLL: a nationwide cohort study
Early stimulated immune responses predict clinical disease severity in hospitalized COVID-19 patients
Patients with CLL have a lower risk of death from COVID-19 in the Omicron era
Prediction of clinical outcome in CLL based on recurrent gene mutations, CLL-IPI variables, and (para)clinical data
Minimal residual disease-guided stop and start of venetoclax plus ibrutinib for patients with relapsed or refractory chronic lymphocytic leukaemia (HOVON141/VISION): primary analysis of an open-label, randomised, phase 2 trial
Pre-diagnostic trajectories of lymphocytosis predict time to treatment and death in patients with chronic lymphocytic leukemia
Identifying patients with chronic lymphocytic leukemia without need of treatment: End of endless watch and wait?
[Chronic lymphocytic leukaemia].
Chronic lymphocytic leukaemia clones are detectable decades before diagnosis
Facilitating EMA binding test performance using fluorescent beads combined with next‐generation sequencing
Improved Survival Among Hospitalized Patients With Coronavirus Disease 2019 (COVID-19) Treated With Remdesivir and Dexamethasone. A Nationwide Population-Based Cohort Study
Clinical Outcomes in Patients with Multi-Hit TP53 Chronic Lymphocytic Leukemia Treated with Ibrutinib
Prognostic factors of 90-day mortality in patients hospitalised with COVID-19.
Higher-order connections between stereotyped subsets: implications for improved patient classification in CLL
Missing publications? Search for publications with a matching author name.